These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5905317)

  • 1. The structural studies of formycin and formycin B.
    Koyama G; Maeda K; Umezawa H; Iitaka Y
    Tetrahedron Lett; 1966 Feb; 6():597-602. PubMed ID: 5905317
    [No Abstract]   [Full Text] [Related]  

  • 2. The studies on the degradation products of formycin and formycin B.
    Kawamura K; Fakatsu S; Murase M; Koyama G; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1966 Mar; 19(2):91-2. PubMed ID: 5952899
    [No Abstract]   [Full Text] [Related]  

  • 3. The studies on the chemical derivations of formycin and formycin B.
    Watanabe S; Matsuhashi G; Fukatsu S; Koyama G; Maeda K; Umezawa H
    J Antibiot (Tokyo); 1966 Mar; 19(2):93-6. PubMed ID: 5952900
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on formycin and formycin B phosphates.
    Sawa T; Fukagawa Y; Shimauchi Y; Ito K; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1965 Nov; 18(6):259-66. PubMed ID: 5898479
    [No Abstract]   [Full Text] [Related]  

  • 5. Formycin B and its relation to formycin.
    Koyama G; Umezawa H
    J Antibiot (Tokyo); 1965 Jul; 18(4):175-7. PubMed ID: 5898331
    [No Abstract]   [Full Text] [Related]  

  • 6. Crystal structure and molecular conformation of formycin monohydrates. Possible origin of the anomalous circular dichroic spectra in formycin mono- and polynucleotides.
    Prusiner P; Brennan T; Sundaralingam M
    Biochemistry; 1973 Mar; 12(6):1196-202. PubMed ID: 4688865
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural requirements for formycin activity.
    Kunimoto T; Wakashiro T; Okamura I; Asajima T; Hori M
    J Antibiot (Tokyo); 1968 Jul; 21(7):468-70. PubMed ID: 5708319
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral effect of formycin and formycin B.
    Takeuchi T; Iwanaga J; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1966 Nov; 19(6):286-7. PubMed ID: 6013241
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism and mechanism of action of formycin B in Leishmania.
    Rainey P; Santi DV
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic phosphates of formycin.
    Makabe O; Miyadera A; Kinoshita M; Umezawa S
    J Antibiot (Tokyo); 1978 May; 31(5):456-67. PubMed ID: 209007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of formycin to formycin B and their biological activities.
    Umezawa H; Sawa T; Fukagawa Y; Koyama G; Murase M; Hamada M; Takeuchi T
    J Antibiot (Tokyo); 1965 Jul; 18(4):178-81. PubMed ID: 5898332
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic conversion of formycin B to formycin A and to oxoformycin B in Nocardia interforma.
    Sawa T; Fukagawa Y; Homma I; Wakashiro T; Takeuchi T
    J Antibiot (Tokyo); 1968 May; 21(5):334-9. PubMed ID: 4973121
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
    Berman JD; Rainey P; Santi DV
    J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-b)pyridazines related to formycin prepared via ring closure of pyridazine precursors.
    Kang Y; Larson SB; Robins RK; Revankar GR
    J Med Chem; 1989 Jul; 32(7):1547-51. PubMed ID: 2738890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
    Nolan LL; Berman JD; Giri L
    Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3- -D-ribofuranosylpyrasolo(4,3-d)pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin B.
    Long RA; Lewis AF; Robins RK; Townsend LB
    J Chem Soc Perkin 1; 1971; 13():2443-6. PubMed ID: 5166604
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of aminoglycosides and other antibiotics with actin.
    Someya A; Tanaka N
    J Antibiot (Tokyo); 1979 Feb; 32(2):156-60. PubMed ID: 155669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclonucleoside derivatives of formycin.
    Makabe O; Nakamura M; Umezawa S
    J Antibiot (Tokyo); 1975 Jun; 28(6):492-5. PubMed ID: 1150543
    [No Abstract]   [Full Text] [Related]  

  • 19. Biosynthesis of formycin. Formation of formycin from formycin B.
    Ochi D; Yashima S; Eguchi Y
    J Antibiot (Tokyo); 1975 Dec; 28(12):965-73. PubMed ID: 1206009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of adenosine kinase in the phosphorylation of formycin B in CHO cells.
    Mehta KD; Gupta RS
    Biochem Biophys Res Commun; 1985 Jul; 130(2):910-7. PubMed ID: 2992490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.